Narrative review / 2015
Approved weight-loss medications are useful adjuncts to lifestyle changes for patients unsuccessful with diet and exercise alone, according to guidelines.
An Endocrine Society-appointed Task Force developed evidence-based clinical practice guidelines for the pharmacological management of obesity using the GRADE system and two systematic reviews. The guidelines concluded that medications approved for chronic weight management serve as useful adjuncts to lifestyle changes for patients who have been unsuccessful with diet and exercise alone. Furthermore, because many drugs prescribed for conditions such as diabetes and depression impact weight, prescribing medications with favorable weight profiles can aid obesity prevention and management.
- Study type
- Clinical practice guideline with systematic reviews
- Who was studied
- Patients with obesity, obesity-associated risk factors, and comorbidities
- What was measured
- Pharmacological management of obesity and weight outcomes
THE PAPER
Pharmacological management of obesity: an endocrine Society clinical practice guideline.
Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD, Endocrine Society. J Clin Endocrinol Metab, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.